IHME logo

Damian Santomauro

Affiliate Assistant Professor

Dr. Damian Santomauro is an Affiliate Assistant Professor of Health Metrics Sciences at the Institute for Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. He is a research fellow for the Psychiatric Epidemiology and Burden of Disease (PEABOD) Research Group based at the Queensland Centre for Mental Health Research (QCMHR), Queensland, Australia. He is also an affiliate assistant professor at the Institute for Health Metrics and Evaluation (IHME), University of Washington, for his work on the Global Burden of Disease Study where he is responsible for the epidemiological modeling of autism spectrum disorders (ASD), fetal alcohol syndrome, and alcohol dependence. Damian’s PhD investigated emotion regulation in adolescents and young adults with ASD. This project involved managing the first randomized controlled trial of a group cognitive behavioral intervention targeting depression in adolescents with ASD ever conducted. Damian has a keen interest in statistics and research methodology and currently acts as PEABOD’s resident statistician.

Publications

Showing 1 - 5 of 25
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 17 April 2024. doi: 10.1016/S0140-6736(24)00757-8.
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 3 April 2024. doi: 10.1016/S0140-6736(24)00367-2.
GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting  the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. 14 March 2024. doi:10.1016/S1474-4422(24)00038-3.
Santomauro DF, Purcell C, Whiteford HA, et al. Grading disorder severity and averted burden by access to treatment within the GBD framework: a case study with anxiety disorders. The Lancet Psychiatry. April 2023. doi: 10.1016/S2215-0366(23)00037-8.
Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 10 October 2022. doi: 10.1001/jama.2022.18931.